Atorvastatin, tablets, 20 mg each;Epinephrine 1.82 mg/ml, solution for injection, ampoule;Amoxicillin and clavulanic acid, powder for injections/infusions 1.2 g;Amiodarone, solution for injection, 50 mg/ml, 3 ml each;Clopidogrel, film-coated tablets, 75 mg each;Pancreatin, Lipolytic units: 8000;Hydrogen peroxide, solution, 3%, 100 ml each;Ethyl alcohol 96% 100 ml.;Chloropyramine, solution for injection, 20 mg/ml, 1 ml each;Human insulin (short-acting), solution for injection, 100 U/ml, vial, 5 m
By: Natalia Kurganyuk๐ UkraineClosed
Key Information
| Reference | GB-UA-2026-11-16-014819-a |
|---|
| Deadline | Nov 19, 2026 12:00 AM |
|---|
| Estimated Value | UAH 46,418,699.00 |
|---|
| Category | Advertising & Media |
|---|
| Competition Type | ICB |
|---|
| Funding Source | Self-Funded |
|---|
| Country | Ukraine |
|---|
| Address | 21018, Ukraine, Vinnytsia region, Vinnytsia, st.Stusa V., building 11 |
|---|
| Published | Nov 16, 2026 |
|---|
Description
Atorvastatin, tablets, 20 mg each;Epinephrine 1.82 mg/ml, solution for injection, ampoule;Amoxicillin and clavulanic acid, powder for injections/infusions 1.2 g;Amiodarone, solution for injection, 50 ...
Full details are available after unlocking this tender.